(19)
(11) EP 3 307 262 A1

(12)

(43) Date of publication:
18.04.2018 Bulletin 2018/16

(21) Application number: 16738352.0

(22) Date of filing: 15.06.2016
(51) International Patent Classification (IPC): 
A61K 31/192(2006.01)
A61K 31/44(2006.01)
 A61K 31/216(2006.01)
A61P 21/00(2006.01)
(86) International application number:
PCT/DK2016/050186
(87) International publication number:
WO 2016/202341 (22.12.2016 Gazette 2016/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 15.06.2015 US 201562175590 P

(71) Applicant: NMD Pharma ApS
8200 Århus N (DK)

(72) Inventors:
  • HOLM PEDERSEN, Thomas
    8240 Risskov (DK)
  • BROCH-LIPS, Martin
    8541 Skødstrup (DK)
  • ELSBORG OLESEN, Claus
    8230 Åbyhøj (DK)
  • LABELLE, Marc
    Basking Ridge, New Jersey 07920 (US)
  • BÆKGAARD NIELSEN, Ole
    8250 Egå (DK)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS